JAZZ - Latest News
Jazz Pharmaceuticals plc (JAZZ), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $14.58B. Trailing twelve-month P/E ratio is 487.62. Beta to the broader market is 0.27.
The article list below shows the most recent JAZZ headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent JAZZ Headlines
Does Epidiolex Make Jazz Pharmaceuticals a Unique Cannabis Stock?
zacks.com - May 13, 2026
JAZZ gains unique cannabis exposure through Epidiolex as strong sales growth and patent protection boost long-term visibility.
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
prnewswire.com - May 12, 2026
DUBLIN, May 12, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that company management will participate in fireside chat
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum Stock
zacks.com - May 12, 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre
International Markets and Jazz (JAZZ): A Deep Dive for Investors
zacks.com - May 11, 2026
Examine the evolution of Jazz's (JAZZ) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
zacks.com - May 8, 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre
How News Affects JAZZ Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track JAZZ's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked JAZZ news questions
- What is the latest JAZZ news headline?
- The most recent JAZZ headline (May 13, 2026) is "Does Epidiolex Make Jazz Pharmaceuticals a Unique Cannabis Stock?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the JAZZ news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What JAZZ news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual JAZZ options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.